A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment
Clinical trial NCT06147830 · COMPLETED
Trial details
- NCT number
- NCT06147830
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-04
- Primary completion
- 2024-11-30
- Enrollment
- 2202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.